Press "Enter" to skip to content

New patent for Lantheus Medcl drug DEFINITY

0
Copyright © DrugPatentWatch. Originally published at New patent for Lantheus Medcl drug DEFINITY

Annual Drug Patent Expirations for DEFINITY
Annual Drug Patent Expirations for DEFINITY

Definity is a drug marketed by Lantheus Medcl and is included in one NDA. There are four patents protecting this drug.

This drug has forty-two patent family members in fourteen countries.

The generic ingredient in DEFINITY is perflutren. Additional details are available on the perflutren profile page.

For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com

Make Better Decisions with DrugPatentWatch

Get the Daily Briefing or Try a trial

Copyright © DrugPatentWatch. Originally published at New patent for Lantheus Medcl drug DEFINITY
    Get the DrugPatentWatch Daily Briefing

    ✓ Patent Expirations and Generic Entry

    ✓ Insightful Articles & Case Studies

    ✓ Patent Litigation & Challenges

    ✓ 505(b)(2) & Biosimilars

    ✓ Industry Trends

    Do NOT follow this link or you will be banned from the site!